Fredun Pharmaceuticals Acquires 26% Stake in ₹300 Crore-Valued Goodman Vetcare
Fredun Pharmaceuticals Ltd · Press Release · 22 Sept 2026, 2:50 pm
Fredun Pharmaceuticals Acquires 26% Stake in ₹300 Crore-Valued Goodman Vetcare Fredun Pharmaceuticals acquired a 26% stake in Goodman Vetcare, valued at ₹300 crore, strengthening its presence in animal health and veterinary retail. Goodman Vetcare's revenue grew at a 30% annual rate from ₹14.1 crore in FY24 to ₹23.6 crore in FY26. It targets revenues of ~₹40 crore in FY27, ~₹56 crore in FY28, and ~₹100 crore by FY31 via a PAN-India retail expansion of eight new stores across three cities. For FY26, Fredun reported revenue of ₹639.12 crore, EBITDA of ₹94.79 crore, and PAT of ₹33.21 crore.
Original exchange filing (PDF)
More announcements from Fredun Pharmaceuticals Ltd
- Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited. · 16 Nov 2026
- Outcome of the Board Meeting of 'Fredun Pharmaceuticals Limited' ('Company') pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. · 14 Nov 2026
- Report of Monitoring Agency on the use of proceeds raised through Preferential Allotment for the quarters ended March 31, 2026, June 30,2026 and September30, 2026. · 14 Nov 2026
- Statement of Deviation or Variation For the Quarter Ended September 30, 2026 for the Funds raised through Preferential Issue. · 14 Nov 2026
- Intimation of Earnings Conference Call for the Quarter Q2 of FY27 · 16 Nov 2026
- Press Release · 06 Nov 2026
- Approval for National Stock Exchange of India Limited (NSE) Listing Application. · 05 Nov 2026
- Financial results for the quarter ended 30th September, 2026. · 05 Nov 2026
